Search

everythinglearnresearchcommunity

for

Search:↓

Non-scarring hair loss in lupus patients often responds well to treatment and doesn't lead to scarring.

Two patients with lupus had an unusual type of hair loss not typical for the disease.

Tumid lupus erythematosus can cause non-scarring hair loss on the scalp and requires careful diagnosis.

Three characteristics of plasmacytoid dendritic cells help tell apart lupus-related hair loss from LPP.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

A patient with patchy hair loss was successfully treated for Tumid Lupus Erythematosus after other treatments failed.

Increased mucin in the skin might indicate lupus in patients with hair loss, but more research is needed.

A woman with subacute cutaneous lupus erythematosus had widespread skin symptoms triggered by medication and sunlight, which improved with specific treatments.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

A disease causing skin issues in young adult German short-haired pointers is hereditary, with most affected dogs not responding to treatment.

Hydroxychloroquine showed some potential, but overall, the three drugs had limited success in treating lupus in dogs.

Skin issues are common in lupus patients, highlighting the need for thorough skin checks.

Most patients with Cutaneous Lupus Erythematosus are young females, and dermatologists play a key role in diagnosis.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

The Polish Dermatological Society recommends personalized treatment for cutaneous lupus, including lifestyle changes, medications, and monitoring, with specific drugs for severe cases.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Lupus can cause different skin problems, and treatments like quitting smoking and using certain creams or medicines can help.

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

A patient with a rare form of lupus improved after treatment for skin ulcers and hair loss on the face and scalp.

Most patients with systemic lupus erythematosus in Malwa, India, show skin symptoms like photosensitivity and rashes.

A woman with lupus had unusual symptoms like blisters, skin inflammation, and throat ulcers, which improved with steroid and dapsone treatment.

A woman with lupus developed a rare skin condition, which improved with increased medication.

The document concludes that better tools are needed to measure skin disease severity in dermatomyositis and cutaneous lupus erythematosus, and introduces the DSSI and CLASI as reliable instruments.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.